Recombinant Human Antithrombin III: rhATIII

ISSN： 1174-5886

Source： Drugs in R&D, Vol.5, Iss.2, 2004-01, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic and recombinant antithrombin drugs

By Kaiser B. Callas D. Walenga J.M. Fareed J.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 6, 1998-06 ,pp. : 963-985

Informa Healthcare

Access to resources Recommend Favorite

Antithrombin III: no benefit in severe sepsis

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Galsulfase: Arylsulfatase B, BM 102, Recombinant Human Arylsulfatase B, Recombinant Human N-Acetylgalactosamine-4-Sulfatase, rhASB

By Adis International Limited

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 312-315

Adis International

Access to resources Recommend Favorite

Human recombinant erythropoietin (rhEPO) may provide myocardial protection during resuscitation from ventricular fibrillation

Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The Role of Recombinant Human Platelet-derived Growth Factor-BB (rhPDGF-BB) in Orthopaedic Bone Repair and Regeneration

Current Pharmaceutical Design, Vol. 19, Iss. 19, 2013-06 ,pp. : 3384-3390

Bentham Science Publishers

Access to resources Recommend Favorite